{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:23:22Z","timestamp":1770917002292,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.path.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:34:53Z","timestamp":1764624893000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Conjunctival Melanocytic Neoplasia"],"prefix":"10.1016","volume":"19","author":[{"given":"Anna M.","family":"Stagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2025.08.004_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2016.09.034","article-title":"Conjunctival tumors in 5002 cases: comparative analysis of benign versus malignant counterparts: the 2016 james D. Allen lecture","volume":"173","author":"Shields","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.path.2025.08.004_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0161-6420(89)32878-8","article-title":"Benign conjunctival melanocytic lesions: clinicopathologic features","volume":"96","author":"Folberg","year":"1989","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.path.2025.08.004_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2021-0006-RA","article-title":"Conjunctival melanocytic lesions","volume":"146","author":"Bresler","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib4","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2025.08.004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100971","article-title":"Conjunctival melanoma: new insights in tumour genetics and immunology, leading to new therapeutic options","volume":"86","author":"Brouwer","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12885-017-3149-0","article-title":"Validation of an NGS mutation detection panel for melanoma","volume":"17","author":"Reiman","year":"2017","journal-title":"BMC Cancer"},{"issue":"6009","key":"10.1016\/j.path.2025.08.004_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archopht.122.2.167","article-title":"Conjunctival nevi: clinical features and natural course in 410 consecutive patients","volume":"122","author":"Shields","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","article-title":"Conjunctival melanoma in the Netherlands: a nationwide study","volume":"46","author":"Missotten","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","article-title":"Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2013-0245-RS","article-title":"Inflamed conjunctival nevi: histopathological criteria","volume":"138","author":"Choi","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2559.2001.01168.x","article-title":"Differential immunoreactivity of melanocytic lesions of the conjunctiva","volume":"39","author":"Sharara","year":"2001","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.5858\/2009-0522-RAR.1","article-title":"Melanocytic lesions of the conjunctiva","volume":"134","author":"Zembowicz","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib14","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1167\/iovs.04-1449","article-title":"T1799A BRAF mutations in conjunctival melanocytic lesions","volume":"46","author":"Goldenberg-Cohen","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.17-22517","article-title":"BRAF, NRAS, and GNAQ mutations in conjunctival melanocytic nevi","volume":"59","author":"Francis","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archopht.117.9.1121","article-title":"Combined nevi of the conjunctiva","volume":"117","author":"Crawford","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.path.2025.08.004_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2019-314807","article-title":"Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions","volume":"104","author":"\u0160ekoranja","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.path.2025.08.004_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/DAD.0000000000002804","article-title":"Superficial Wnt-activated melanocytic nevi\/melanocytomas with a junctional component: a case series","volume":"46","author":"Ng","year":"2024","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.path.2025.08.004_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000504966","article-title":"Histopathological and molecular features of a conjunctival caruncular deep penetrating nevus","volume":"6","author":"van Ipenburg","year":"2020","journal-title":"Ocul Oncol Pathol"},{"issue":"4","key":"10.1016\/j.path.2025.08.004_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/13816810.2022.2039719","article-title":"Diagnosis of the origin of an epibulbar melanocytic tumor with molecular genomics","volume":"43","author":"Gonzalez-H Leon","year":"2022","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"10.1016\/j.path.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/IOP.0000000000002627","article-title":"Melanoma arising beneath the lateral rectus muscle in a teenager with ocular melanocytosis: possible origin from intrascleral melanocytes","volume":"40","author":"Chiou","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.path.2025.08.004_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0046-8177(99)90197-1","article-title":"Lentigo maligna and malignant melanoma in situ, Lentigo maligna type","volume":"30","author":"Flotte","year":"1999","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0046-8177(85)80061-7","article-title":"Primary acquired melanosis of the conjunctiva","volume":"16","author":"Folberg","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.08.004_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajo.2015.11.003","article-title":"Conjunctival primary acquired melanosis: is it time for a new terminology?","volume":"162","author":"Jakobiec","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.path.2025.08.004_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","article-title":"Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging","volume":"36","author":"Damato","year":"2008","journal-title":"Clin Exp Opthalmol"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2012.254","article-title":"Conjunctival melanoma and melanocytic intra-epithelial neoplasia","volume":"27","author":"Kenawy","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.path.2025.08.004_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajo.2020.10.020","article-title":"Validation of the newly proposed world health organization classification system for conjunctival melanocytic intraepithelial lesions: a comparison with the C-MIN and PAM classification schemes","volume":"223","author":"Milman","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.pas.0000213339.32734.64","article-title":"Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases","volume":"31","author":"Sugiura","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2025.08.004_bib30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bjo.2007.129882","article-title":"Clinical mapping of conjunctival melanomas","volume":"92","author":"Damato","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.path.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bjophthalmol-2020-317772","article-title":"Primary acquired melanosis\/melanoma: utility of conjunctival map biopsy","volume":"106","author":"Soto","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.path.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/DAD.0000000000002201","article-title":"PRAME expression in junctional melanocytic proliferations of the conjunctiva: a potential biomarker for primary acquired melanosis\/conjunctival melanocytic intraepithelial lesions","volume":"44","author":"Huang","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2025.08.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.02.002","volume":"134","author":"Mudhar","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.08.004_bib34","first-page":"185e204","article-title":"Management of conjunctival malignant melanoma: a review and update","volume":"9","author":"Wong","year":"2014","journal-title":"Expert Rev Opthalmol"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.IOP.0000055826.30486.CC","article-title":"Topical mitomycin treatment for primary acquired melanosis of the conjunctiva","volume":"19","author":"Yuen","year":"2003","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/PAS.0000000000001344","article-title":"Greater tumor thickness, ulceration, and positive sentinel lymph node are associated with worse prognosis in patients with conjunctival melanoma: implications for future AJCC classifications","volume":"43","author":"Esmaeli","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.08.004_bib37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/OPTH.S187364","article-title":"Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights","volume":"13","author":"Mor","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.path.2025.08.004_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib39","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/genes14091668","article-title":"Genetic aspects of conjunctival melanoma: a review","volume":"14","author":"Chang","year":"2023","journal-title":"Genes"},{"issue":"15","key":"10.1016\/j.path.2025.08.004_bib40","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.3390\/cancers13153836","article-title":"Definition of biologically distinct groups of conjunctival melanomas according to etiological factors and implications for precision medicine","volume":"13","author":"Gardrat","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.path.2025.08.004_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/aos.13007","article-title":"BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.path.2025.08.004_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2022.01.016","article-title":"Mutational landscape and outcomes of conjunctival melanoma in 101 patients","volume":"129","author":"Lally","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.path.2025.08.004_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.humpath.2020.07.020","article-title":"Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67","volume":"103","author":"Milman","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2025.08.004_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1066896911435697","article-title":"P16ink4a expression in benign and malignant melanocytic conjunctival lesions","volume":"20","author":"Zoroquiain","year":"2012","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41416-018-0046-5","article-title":"NF1 mutations in conjunctival melanoma","volume":"118","author":"Scholz","year":"2018","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib46","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jamaophthalmol.2019.4237","article-title":"Integrative exome and transcriptome analysis of conjunctival melanoma and its potential application for personalized therapy","volume":"137","author":"Demirci","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"16","key":"10.1016\/j.path.2025.08.004_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612988","article-title":"ATRX loss in the development and prognosis of conjunctival melanoma","volume":"24","author":"van Ipenburg","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.path.2025.08.004_bib48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1541-7786.MCR-20-0839","article-title":"Meta-analysis and systematic review of the genomics of mucosal melanoma","volume":"19","author":"Broit","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib49","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaophthalmol.2017.4837","article-title":"Molecular characteristics of conjunctival melanoma using whole-exome sequencing","volume":"135","author":"Swaminathan","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.path.2025.08.004_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.path.2025.08.004_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009201","article-title":"Genomic and transcriptomic landscape of conjunctival melanoma","volume":"16","author":"Cisarova","year":"2020","journal-title":"PLoS Genet"},{"issue":"11","key":"10.1016\/j.path.2025.08.004_bib52","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/ijms22115784","article-title":"Molecular genetics of conjunctival melanoma and prognostic value of TERT promoter mutation analysis","volume":"22","author":"van Poppelen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.path.2025.08.004_bib53","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/bjophthalmol-2020-317405","article-title":"Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features","volume":"105","author":"van Ipenburg","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.path.2025.08.004_bib54","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1167\/iovs.14-14901","article-title":"Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions","volume":"5","author":"Koopmans","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40135-025-00334-9","article-title":"Emerging techniques in the treatment of conjunctival melanoma","volume":"13","author":"Li","year":"2025","journal-title":"Curr Ophthalmol Rep"},{"issue":"6","key":"10.1016\/j.path.2025.08.004_bib56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/08820538.2025.2458658","article-title":"Immune checkpoint inhibitors in the treatment of ocular surface cancers: a review","volume":"40","author":"Li","year":"2025","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.path.2025.08.004_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/tjo.TJO-D-24-00109","article-title":"Current findings of genetic alterations and associated targeted therapies of conjunctival melanocytic neoplasms","volume":"15","author":"Wang","year":"2025","journal-title":"Taiwan J Ophthalmol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:47:31Z","timestamp":1770223651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918125000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1875918125000534"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2025.08.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjunctival Melanocytic Neoplasia","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}